U.S. flag

An official website of the United States government

NM_000540.3(RYR1):c.1597C>T (p.Arg533Cys) AND RYR1-related disorder

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 23, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000802081.5

Allele description [Variation Report for NM_000540.3(RYR1):c.1597C>T (p.Arg533Cys)]

NM_000540.3(RYR1):c.1597C>T (p.Arg533Cys)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.3(RYR1):c.1597C>T (p.Arg533Cys)
Other names:
NM_000540.2(RYR1):c.1597C>T
HGVS:
  • NC_000019.10:g.38455471C>T
  • NG_008866.1:g.26772C>T
  • NM_000540.3:c.1597C>TMANE SELECT
  • NM_001042723.2:c.1597C>T
  • NP_000531.2:p.Arg533Cys
  • NP_000531.2:p.Arg533Cys
  • NP_001036188.1:p.Arg533Cys
  • LRG_766t1:c.1597C>T
  • LRG_766:g.26772C>T
  • LRG_766p1:p.Arg533Cys
  • NC_000019.9:g.38946111C>T
  • NC_000019.9:g.38946111C>T
  • NM_000540.2:c.1597C>T
  • P21817:p.Arg533Cys
  • p.(Arg533Cys)
Protein change:
R533C
Links:
UniProtKB: P21817#VAR_045708; dbSNP: rs193922768
NCBI 1000 Genomes Browser:
rs193922768
Molecular consequence:
  • NM_000540.3:c.1597C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042723.2:c.1597C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
RYR1-related disorder
Synonyms:
RYR1-Related Disorders; RYR1-related condition
Identifiers:
MedGen: CN239331

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000941895Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 23, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles.

Tammaro A, Bracco A, Cozzolino S, Esposito M, Di Martino A, Savoia G, Zeuli L, Piluso G, Aurino S, Nigro V.

Clin Chem. 2003 May;49(5):761-8.

PubMed [citation]
PMID:
12709367

Skeletal muscle ryanodine receptor mutations associated with malignant hyperthermia showed enhanced intensity and sensitivity to triggering drugs when expressed in human embryonic kidney cells.

Sato K, Roesl C, Pollock N, Stowell KM.

Anesthesiology. 2013 Jul;119(1):111-8. doi: 10.1097/ALN.0b013e31828cebfe.

PubMed [citation]
PMID:
23459219
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000941895.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 533 of the RYR1 protein (p.Arg533Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with malignant hyperthermia (PMID: 12709367). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 133102). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects RYR1 function (PMID: 23459219). This variant disrupts the p.Arg533 amino acid residue in RYR1. Other variant(s) that disrupt this residue have been observed in individuals with RYR1-related conditions (PMID: 20681998), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024